960201-81-4

960201-81-4 structure

Name: SD 1008
Chemical Name: Dimethyl (1R,5R,6R,7S)-8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-en e-6,7-dicarboxylate-dimethyl (1S,5S,6S,7R)-8-benzyl-4-oxo-8-aza bicyclo[3.2.1]oct-2-ene-6,7-dicarboxylate (1:1)
CAS Number: 960201-81-4
Molecular Formula: C₁₈H₁₉NO₅
Molecular Weight: 329.35
Catalog: Signaling Pathways Apoptosis Apoptosis
Create Date: 2017-11-17 03:00:10
Modify Date: 2025-08-25 18:40:41
SD-1008 is a potent JAK inhibitor. SD-1008 inhibits tyrosyl phosphorylation of STAT3, JAK2 and Src. SD-1008 also reduces STAT3-dependent luciferase activity. SD-1008 enhances apoptosis induced by Paclitaxel in ovarian cancer cells via directly blocking the JAK-STAT3 signaling pathway[1].

Name	Dimethyl (1R,5R,6R,7S)-8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-en e-6,7-dicarboxylate-dimethyl (1S,5S,6S,7R)-8-benzyl-4-oxo-8-aza bicyclo[3.2.1]oct-2-ene-6,7-dicarboxylate (1:1)

Description	SD-1008 is a potent JAK inhibitor. SD-1008 inhibits tyrosyl phosphorylation of STAT3, JAK2 and Src. SD-1008 also reduces STAT3-dependent luciferase activity. SD-1008 enhances apoptosis induced by Paclitaxel in ovarian cancer cells via directly blocking the JAK-STAT3 signaling pathway[1].
Related Catalog	Signaling Pathways >> Stem Cell/Wnt >> STAT Signaling Pathways >> Apoptosis >> Apoptosis Research Areas >> Cancer Signaling Pathways >> JAK/STAT Signaling >> JAK Signaling Pathways >> Epigenetics >> JAK Signaling Pathways >> Stem Cell/Wnt >> JAK Signaling Pathways >> JAK/STAT Signaling >> STAT
Target	JAK2 STAT3
References	[1]. Duan Z, et al. 8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells. Mol Pharmacol. 2007;72(5):1137-1145.